In a world where the pressure grows for those who aren’t willing to receive COVID vaccination, companies are testing their shots on children. Moderna, the company that developed one of the most well-known vaccines for COVID, announced that it expects to report data from a COVID vaccine trial for the little ones: children aged 2 to 5 years old.
The information is brought by Reuters, and the trial data is expected to arrive in March 2022. The company declared:
We expect to report data in children 2-5 years of age in March. If the data is supportive and subject to regulatory consultation, Moderna may proceed with regulatory filings for children 2-5 years of age thereafter.
Otherwise, Moderna’s vaccine is very trusted across the medical world. Here’s what the World Health Organization (WHO) has to say about vaccinating pregnant women:
Given the adverse consequences of COVID-19 during pregnancy and the increasing data supporting a favorable safety profile of mRNA-1273 in pregnancy, WHO recommends the use of mRNA-1273 in pregnant individuals. WHO does not recommend pregnancy testing prior to vaccination. WHO does not recommend delaying pregnancy or terminating pregnancy because of vaccination.
The Omicron variant is believed to currently be causing most of the COVID infections across the world. Although it’s far more contagious than other strains, Omicron is even considered a “milder form of COVID” by Dr. Scott Gottlieb. We’re talking about the former Commissioner of the Food and Drug Administration (FDA). He made the claim as quoted by CBCNews.com. However, doctors continue to believe that getting vaccinated for COVID is a good idea.
The USA is one of the countries where Omicron has become dominant, and the country reports hundreds of thousands of infections every day.